NOTCH1 and diffuse large B-cell lymphoma: Functionally relevant gain-of-function mutations of NOTCH1 and NOTCH2 were identified in up to 8 % of DLBCL patients and postulated to act as likely drivers of DLBCL pathogenesis [16, 553, 554].